Results
Fasting lipid profile measurements demonstrated a significant decrease (P=.023) in the calculated LDL-C concentration following 12 weeks of supplementation compared to the concentrations observed during averaged baseline visits (Fig. 1 and Table 2). Additionally, a highly significant (P=.006) reduction in total cholesterol/HDL was also noted following 12 weeks of CAPROS supplementation (Fig. 1). The concentration of CRP increases when there is systemic inflammation.15 A high concentration of CRP is considered a risk factor for heart disease.15 A more sensitive CRP test, called a hs-CRP assay, is a promising marker of coronary heart disease.16 Although a trend of decreased plasma CRP levels was observed following 12 weeks of supplementation, the effect did not reach significance (P=.107). However, a highly significant (P